CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis
AbstractThe purpose of our work was to select phages displaying peptides capable of binding to vascular markers present in human atheroma, and validate their capacity to target the vascular markers in vitro and in low-density lipoprotein receptor knockout (LDLr−/−) mouse model of atherosclerosis. By peptide fingerprinting on human atherosclerotic tissues, we selected and isolated four different peptides sequences, which bind to atherosclerotic lesions and share significant similarity to known human proteins with prominent roles in atherosclerosis. The CTHRSSVVC-phage peptide displayed the strongest reactivity with human carotid atherosclerotic lesions (p < 0.05), when compared to tissues from normal carotid arteries. This peptide sequence shares similarity to a sequence present in the fifth scavenger receptor cysteine-rich (SRCR) domain of CD163, which appeared to bind to CD163, and subsequently, was internalized by macrophages. Moreover, the CTHRSSVVC-phage targets atherosclerotic lesions of a low-density lipoprotein receptor knockout (LDLr−/−) mouse model of atherosclerosis in vivo to High-Fat diet group versus Control group. Tetraazacyclododecane-1,4,7,10-tetraacetic acid-CTHRSSVVC peptide (DOTA-CTHRSSVVC) was synthesized and labeled with 111InCl3 in >95% yield as determined by high performance liquid chromatography (HPLC), to validate the binding of the peptide in atherosclerotic plaque specimens. The results supported our hypothesis that CTHRSSVVC peptide has a remarkable sequence for the development of theranostics approaches in the treatment of atherosclerosis and other diseases. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 802 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Silva, R.A.; Giordano, R.J.; Gutierrez, P.S.; Rocha, V.Z.; Rudnicki, M.; Kee, P.; Abdalla, D.S.P.; Puech-Leão, P.; Caramelli, B.; Arap, W.; Pasqualini, R.; Meneghetti, J.C.; Marques, F.L.N.; Khoobchandani, M.; Katti, K.V.; Lugão, A.B.; Kalil, J. CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis. Int. J. Mol. Sci. 2016, 17, 1383.
Silva RA, Giordano RJ, Gutierrez PS, Rocha VZ, Rudnicki M, Kee P, Abdalla DSP, Puech-Leão P, Caramelli B, Arap W, Pasqualini R, Meneghetti JC, Marques FLN, Khoobchandani M, Katti KV, Lugão AB, Kalil J. CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis. International Journal of Molecular Sciences. 2016; 17(9):1383.Chicago/Turabian Style
Silva, Rosemeire A.; Giordano, Ricardo J.; Gutierrez, Paulo S.; Rocha, Viviane Z.; Rudnicki, Martina; Kee, Patrick; Abdalla, Dulcinéia S.P.; Puech-Leão, Pedro; Caramelli, Bruno; Arap, Wadih; Pasqualini, Renata; Meneghetti, José C.; Marques, Fabio L.N.; Khoobchandani, Menka; Katti, Kattesh V.; Lugão, Ademar B.; Kalil, Jorge. 2016. "CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis." Int. J. Mol. Sci. 17, no. 9: 1383.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.